Chagas' disease and the involvement of the autonomic nervous system

Ademir Batista da Cunha1

  • 1Universidade Federal Fluminense, Instituto Nacional de Cardiología, Rio de Janeiro, Brasil. adanton@uol.com.br

Insights

Chagas disease cardiopathy pathogenesis is linked to autonomic nervous system dysfunction. Research highlights parasympathetic reduction and sympathetic involvement, impacting heart function and arrhythmias.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Neuroscience

Background:

  • Chagas disease affects millions in Latin America, causing chronic Chagas cardiopathy.
  • Pathogenesis theories include direct Trypanosoma cruzi lesion, autonomic nervous system (ANS) dysfunction, microvascular disease, immune reactions, and extracellular matrix alterations.
  • The neurogenic concept, emphasizing ANS involvement, has been a central focus since Carlos Chagas's initial research.

Discussion:

  • Pioneering studies by Köberle in the 1950s indicated reduced parasympathetic nerve cells in Chagas patients, suggesting a "parasympathetic reduction" with sympathetic predominance.
  • Systematic studies on autonomic function in the 1960s by Dalmo Amorim and subsequent research in Brazil, Argentina, and Venezuela explored cardiac autonomic control.
  • Research has identified functional involvement of the parasympathetic system (Ribeirão Preto, Brasília) and cardiovascular sympathetic dysfunction (Córdoba).

Key Insights:

  • Functional sympathetic denervation in Chagas disease is characterized by heart rate changes assessed via tilt tests.
  • Autonomic nervous system dysfunction is a key factor modulating complex ventricular arrhythmias in chronic Chagas patients.
  • Experimental evidence shows that serum from Chagas patients with arrhythmias and dilated cardiopathy adversely affects cardiac conduction systems, unlike serum from asymptomatic patients.

Outlook:

  • Further investigation into the neurogenic concept offers significant opportunities to understand ventricular involvement in chronic Chagas cardiopathy.
  • Understanding ANS dysfunction is crucial for developing targeted therapies for Chagas disease complications.
  • Continued research integrating clinical, experimental, and epidemiological data will refine our understanding of Chagas cardiopathy pathogenesis.

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Autonomic Nervous System: Overview01:26

Autonomic Nervous System: Overview

The human nervous system is divided into two main parts: the central nervous system (CNS) and the peripheral nervous system (PNS). The CNS is composed of the brain and spinal cord, while the PNS contains nerve cells, clusters of nerve cells, and the sensory receptors that are outside the CNS. The PNS has two types of nerve cells: sensory (afferent) and motor (efferent). Sensory cells send signals to the CNS from receptors, and motor cells carry signals from the CNS to organs, muscles, and...